Alison G. Freifeld

15.3k citations

97 papers · 7.4k indexed · 3 hit papers · h-index 37

Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 17
Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility 24
Oncology top 0.5%
- Neutropenia and Cancer Infections 34
Epidemiology top 0.5%
- Fungal Infections and Studies 18
- Cytomegalovirus and herpesvirus research 12
- Pneumocystis jirovecii pneumonia detection and treatment 8
Emergency Medicine top 0.5%
- Hematological disorders and diagnostics 8
Small Animals
- Infectious Diseases and Mycology 10

Co-authors: James I. Ito Michael Boeckh Issam Raad Kenneth V. I. Rolston Jo‐Anne H. Young John R. Wingard Kent A. Sepkowitz Eric J. Bow
Cited by: Clinical Biochemistry Infectious Diseases Oncology
Journals: New England Journal of Medicine (1 paper)Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)
Partner nations: United States Canada Malaysia

In The Last Decade

Alison G. Freifeld

96 papers receiving 7.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 Clinical Infectious Diseases
2011 Clinical Infectious Diseases
2007 Clinical Infectious Diseases

Peers

Countries citing papers authored by Alison G. Freifeld

Since Specialization

Citations

This map shows the geographic impact of Alison G. Freifeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison G. Freifeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison G. Freifeld more than expected).

Fields of papers citing papers by Alison G. Freifeld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison G. Freifeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison G. Freifeld. The network helps show where Alison G. Freifeld may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alison G. Freifeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison G. Freifeld Line = papers co-authored together Alison G. Freifeld links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The climate crisis and healthcare: What do infection prevention and stewardship professionals need to know? SHILAP Revista de lepidopterología ·Alison G. Freifeld,Alexandra I. Todd,Ali S. Khan	2023	14
2	BK Viremia as a Predictor of Hemorrhagic Cystitis in Adults During the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplantation Transplantation Proceedings ·Varun Kesherwani,L F Guzman Vinasco,Mohammad Awaji,R. Gregory Bociek,Jane L. Meza,Valerie Shostrom,Alison G. Freifeld,Connie J. Gebhart	2018	8
3	Causative Organisms and Associated Antimicrobial Resistance in Healthcare-Associated, Central Line–Associated Bloodstream Infections From Oncology Settings, 2009–2012 Clinical Infectious Diseases ·Isaac See,Alison G. Freifeld,Shelley S. Magill	2016	48
4	Blood Cultures for Persistent Fever in Neutropenic Pediatric Patients Are of Low Diagnostic Yield Journal of the Pediatric Infectious Diseases Society ·Kari Neemann,Alexandra B. Yonts,Fang Qiu,Kari Simonsen,Stefanie Lowas,Alison G. Freifeld	2015	10
5	Reduction in False-Positive Aspergillus Serum Galactomannan Enzyme Immunoassay Results Associated with Use of Piperacillin-Tazobactam in the United States Journal of Clinical Microbiology ·Paschalis Vergidis,Raymund R. Razonable,L. Joseph Wheat,Lynn L. Estes,Angela M. Caliendo,Lindsey R. Baden,John R. Wingard,John W. Baddley,Maha Assi,Steven J. Norris,Pranatharthi Chandrasekar,Ryan K. Shields,Hồng Quân Nguyễn,Alison G. Freifeld,Richard Köhler,Martin B. Kleiman,Thomas J. Walsh,Chadi A. Hage	2014	46
6	Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance^® registry Mycoses ·David L. Horn,Alison G. Freifeld,Mindy G. Schuster,Nkechi Azie,Billy Franks,Carol A. Kauffman	2014	57
7	Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study Critical Care ·Elizabeth D. Hermsen,Michelle K. Zapapas,Melissa Maiefski,Mark E. Rupp,Alison G. Freifeld,André C. Kalil	2011	57
8	A model of tuberculosis transmission and intervention strategies in an urban residential area Computational Biology and Chemistry ·Elsje Pienaar,Aaron M. Fluitt,Scott Whitney,Alison G. Freifeld,Hendrik J. Viljoen	2010	10
9	Valganciclovir for Cytomegalovirus Prevention in Solid Organ Transplant Patients: An Evidence-Based Reassessment of Safety and Efficacy PLoS ONE ·André C. Kalil,Alison G. Freifeld,Elizabeth Lyden,Julie A. Stoner	2009	67
10	Bacterial infection prevention after hematopoietic cell transplantation Bone Marrow Transplantation ·Dan Engelhard,Murat Akova,Michael Boeckh,Alison G. Freifeld,K. A. Sepkowitz,Claudio Viscoli,James C. Wade,Issam Raad	2009	58
11	Evaluation of the coagulation and inflammatory responses in solid organ transplant recipients and donors Clinical Transplantation ·Josh Levitsky,Alison G. Freifeld,Elizabeth Lyden,Julie A. Stoner,Diana F. Florescu,Alan N. Langnas,R. Brian Stevens,Penny Hardiman,Lisa Hill,André C. Kalil	2009	13
12	Guidelines for Antimicrobials in Neutropenic Cancer Patients Alison G. Freifeld	2007	1
13	Sepsis and Solid Organ Transplantation Current Drug Targets ·AC Kalil,H Dakroub,Alison G. Freifeld	2007	32
14	Endemic Fungal Infections (EFIs) among Solid Organ Transplant Recipients (SOTRs) Alison G. Freifeld	2005	1
15	Herpes zoster infection after liver transplantation: A case-control study Liver Transplantation ·Josh Levitsky,André C. Kalil,Jane L. Meza,Glenn E. Hurst,Alison G. Freifeld	2005	19
16	Use of Interferon- in Patients with West Nile Encephalitis: Report of 2 Cases Clinical Infectious Diseases ·André C. Kalil,Marcel P. Devetten,Seema Singh,B Lesiak,David P. Poage,K. Bargenquast,Pierre Fayad,Alison G. Freifeld	2005	74
17	Thromboembolism following removal of femoral venous apheresis catheters in patients with breast cancer Annals of Oncology ·Muhammad Wasif Saif,Susan F. Leitman,Georgie Cusack,M K Horne,Alison G. Freifeld,David Venzon,A Premkumar,K H Cowan,Richard E. Gress,Jo Anne Zujewski,Claude Kasten-Sportès	2004	7
18	West Nile Virus--Associated Encephalitis in Recipients of Renal and Pancreas Transplants: Case Series and Literature Review Clinical Infectious Diseases ·K Ravindra,Alison G. Freifeld,André C. Kalil,David F. Mercer,Wendy J. Grant,Jean Botha,Lucile E. Wrenshall,R. Brian Stevens	2004	64
19	A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy New England Journal of Medicine ·Alison G. Freifeld,Donna Marchigiani,Thomas J. Walsh,Stephen J. Chanock,Linda Lewis,John Hiemenz,Sharon Hiemenz,Jeanne E. Hicks,Vee J. Gill,Seth M. Steinberg,Philip A. Pizzo	1999	271
20	A Controlled Seroprevalence Survey of Primate Handlers for Evidence of Asymptomatic Herpes B Virus Infection The Journal of Infectious Diseases ·Alison G. Freifeld,Julia K. Hilliard,J. Southers,M.J. Murray,Barbara Savarese,Jürgen M. Schmitt,Stephen E. Straus	1995	38

About Alison G. Freifeld

Alison G. Freifeld is a scholar working on Microbiology, Clinical Biochemistry and Infectious Diseases, having authored 97 papers that have together received 7.4k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (34 papers), Antifungal resistance and susceptibility (24 papers), Fungal Infections and Studies (18 papers), Bacterial Identification and Susceptibility Testing (17 papers), Cytomegalovirus and herpesvirus research (12 papers), Infectious Diseases and Mycology (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Hematological disorders and diagnostics (8 papers). The work is most often cited by research in Clinical Biochemistry (1.6k citations), Infectious Diseases (2.8k citations) and Oncology (3.7k citations). Alison G. Freifeld has collaborated with scholars based in United States, Canada and Malaysia. Frequent co-authors include James I. Ito, Michael Boeckh, Issam Raad, Kenneth V. I. Rolston, Jo‐Anne H. Young, John R. Wingard, Kent A. Sepkowitz, Eric J. Bow, Craig A. Mullen and L. Joseph Wheat. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact